Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06601465 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

COgnitioN With VERiciGuat Evaluation in Heart Failure

Study acronym: CONVERGE-HF
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 11 months later Jul 2026 → Jul 16, 2028
See other at-risk trials from University of Alberta

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jul 2026 to Jul 16, 2028
    • Study completion pushed from May 2027 to Jul 16, 2028
    v7
  2. Eligibility criteria shortened, about 8 wordsv6
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Apr 2025 to Jun 3, 2025
    • Site details revised at 4 of 4 sites
    v5
  4. Start date: Feb 2025 to Apr 2025v4
  5. Study sites: 3 to 4v3
  6. Start date: Nov 2024 to Feb 2025v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
CONVERGE-HF is a 4-center pilot phase IIb randomized control trial in ambulatory patients with chronic heart failure (≥ 6 months) and mild-to-moderate cognitive impairment.
Trial Details
NCT Number NCT06601465
Lead Sponsor University of Alberta
Collaborators: Ottawa Heart Institute Research Corporation, Heart and Stroke Foundation of Canada
Conditions
(from sponsor)		 Heart Failure, Cognitive Impairment
Related terms Cognitive Dysfunction, Heart Failure
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov